Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Oral Caffeine Intake in Reducing the Severity of Acute Migraine Attack Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals: A Randomized Controlled Trial

NCT07022496 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07022496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07022496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Oral Caffeine Intake in Reducing the Severity of Acute Migraine Attack Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals: A Randomized Controlled Trial
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Recruiting
Start date
April 26, 2023
Completion date
August 31, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine disease, migraine headache, migraine headache, with or without aura, migraine, acute